Jakob Dupont - Aug 16, 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, Head of R&D
Signature
/s/ David Tucker, Attorney-in-Fact for Jakob Dupont
Stock symbol
ATRA
Transactions as of
Aug 16, 2022
Transactions value $
-$20,760
Form type
4
Date filed
8/18/2022, 06:21 PM
Previous filing
Aug 24, 2023
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$20.8K -4.12K -2.53% $5.03 159K Aug 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.